ENTITY
YiChang HEC ChangJiang Pharmaceutical

YiChang HEC ChangJiang Pharmaceutical (1558 HK)

137
Analysis
Health Care • China
YiChang HEC ChangJiang Pharmaceutical develops, manufactures, and sells pharmaceutical products, focusing on anti-viral, endocrine and metabolic, and cardiovascular diseases. Key products include Kewei (oseltamivir phosphate), Oumeining (telmisartan), and Ertongshu (benzbromarone). The company was founded in 2001 and is headquartered in Dongguan, China.
more
bullish•PointsBet Holdings
•30 Jul 2025 11:59

PointsBet (PBH AU): Either Betr Pulls A Rabbit Out Of The Hat, Or Walks

I can see Mixi waiving the acceptance condition and declaring term unconditional. Trading at terms. If in, sell here. If not in, avoid unless...

Logo
395 Views
Share
•28 Jul 2025 10:28

Ainsworth Game Technology (AGI AU): 29th August Vote On Novomatic's "Low-Balled Offer"

I think this gets up. And that's a chunky franked dividend with respect to the Offer price. For those who can take advantage. Key shareholders have...

Logo
545 Views
Share
bullish•Shibaura Electronics
•28 Jul 2025 02:03

Merger Arb Mondays (28 Jul) - Shibaura, Abacus Storage, Insignia, Mayne, Santos, ENN, Smart Share

I summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...

Logo
1k Views
Share
bearish•CK Hutchison
•27 Jul 2025 09:44

Weekly Deals Digest (27 Jul) - CK Hutchison, Pacific Industrial, FHT, Abacus, PointsBet, NSDL

A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, NZ, Singapore, Japan, Indonesia,...

Logo
553 Views
Share
bullish•Insignia Financial
•27 Jul 2025 05:15

(Mostly) Asia-Pac M&A: Pacific Ind., Insignia Fin., PointsBet, New World Res., Frasers Hospitality

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
696 Views
Share
x